Zobrazeno 1 - 10
of 1 591
pro vyhledávání: '"Drake Rr"'
Autor:
Taylor HB; Department of Pharmacology & Immunology, Medical University of South Carolina, Charleston, SC, USA., Dunne JB; Department of Pharmacology & Immunology, Medical University of South Carolina, Charleston, SC, USA., Lim MJ; AmberGen, Inc., Billerica, MA, USA., Yagnik G; AmberGen, Inc., Billerica, MA, USA., Rothschild KJ; AmberGen, Inc., Billerica, MA, USA.; Department of Physics and Photonics Center, Boston University, Boston, MA, USA., Mehta A; Department of Pharmacology & Immunology, Medical University of South Carolina, Charleston, SC, USA., Drake RR; Department of Pharmacology & Immunology, Medical University of South Carolina, Charleston, SC, USA., Angel PM; Department of Pharmacology & Immunology, Medical University of South Carolina, Charleston, SC, USA. angelp@musc.edu.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2025; Vol. 2884, pp. 305-332.
Spatial omics-based machine learning algorithms for the early detection of hepatocellular carcinoma.
Autor:
Wang M; Medical University of South Carolina, Department of Cell and Molecular Pharmacology, Charleston, SC, 29425, USA., Grauzam S; Medical University of South Carolina, Department of Cell and Molecular Pharmacology, Charleston, SC, 29425, USA.; GlycoPath, Inc, 22 WestEdge St - Suite 400, Charleston, SC, 29403, USA., Bayram MF; Medical University of South Carolina, Department of Cell and Molecular Pharmacology, Charleston, SC, 29425, USA., Dressman J; Medical University of South Carolina, Department of Cell and Molecular Pharmacology, Charleston, SC, 29425, USA., DelaCourt A; Medical University of South Carolina, Department of Cell and Molecular Pharmacology, Charleston, SC, 29425, USA., Blaschke C; Medical University of South Carolina, Department of Cell and Molecular Pharmacology, Charleston, SC, 29425, USA., Liang H; Medical University of South Carolina, Department of Cell and Molecular Pharmacology, Charleston, SC, 29425, USA., Scott D; GlycoPath, Inc, 22 WestEdge St - Suite 400, Charleston, SC, 29403, USA., Huffman G; GlycoPath, Inc, 22 WestEdge St - Suite 400, Charleston, SC, 29403, USA., Black A; HTX Technologies, LLC, Chapel Hill, Chapel Hill, NC, 27516, USA., Ochoa-Rios S; Medical University of South Carolina, Department of Cell and Molecular Pharmacology, Charleston, SC, 29425, USA., Lewin D; Medical University of South Carolina, Department of Pathology and Laboratory Medicine, Charleston, SC, 29425, USA., Angel PM; Medical University of South Carolina, Department of Cell and Molecular Pharmacology, Charleston, SC, 29425, USA., Drake RR; Medical University of South Carolina, Department of Cell and Molecular Pharmacology, Charleston, SC, 29425, USA., Ball L; Medical University of South Carolina, Department of Cell and Molecular Pharmacology, Charleston, SC, 29425, USA., Bethard J; Medical University of South Carolina, Department of Cell and Molecular Pharmacology, Charleston, SC, 29425, USA., Castellino S; GlycoPath, Inc, 22 WestEdge St - Suite 400, Charleston, SC, 29403, USA., Kono Y; University of California San Diego, Department of Medicine, Gastroenterology and Hepatology, San Diego, CA, 92103, USA., Kubota N; University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA., Hoshida Y; University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA., Quirk L; University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA., Yopp A; University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA., Gopal P; University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA., Singal A; University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA., Mehta AS; Medical University of South Carolina, Department of Cell and Molecular Pharmacology, Charleston, SC, 29425, USA. mehtaa@musc.edu.
Publikováno v:
Communications medicine [Commun Med (Lond)] 2024 Dec 03; Vol. 4 (1), pp. 258. Date of Electronic Publication: 2024 Dec 03.
Autor:
Hartig JP; Medical University of South Carolina, Charleston, South Carolina., Bejar K; University of Texas Health Science Center, San Antonio, Texas., Young LEA; Medical University of South Carolina, Charleston, South Carolina., Grimsley G; Medical University of South Carolina, Charleston, South Carolina., Bethard JR; Medical University of South Carolina, Charleston, South Carolina., Troyer DA; Eastern Virginia Medical School, Norfolk, Virginia., Hernandez J; Audie L. Murphy Memorial Veteran's Administration Hospital, San Antonio, Texas., Wu JD; Northwestern Feinberg School of Medicine, Chicago, Illinois., Ippolito JE; Washington University in St. Louis School of Medicine, St. Louis, Missouri., Ball LE; Medical University of South Carolina, Charleston, South Carolina., Gelfond JAL; University of Texas Health Science Center, San Antonio, Texas., Johnson-Pais TL; University of Texas Health Science Center, San Antonio, Texas., Mehta AS; Medical University of South Carolina, Charleston, South Carolina., Leach RJ; University of Texas Health Science Center, San Antonio, Texas., Angel PM; Medical University of South Carolina, Charleston, South Carolina., Drake RR; Medical University of South Carolina, Charleston, South Carolina.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Nov 01; Vol. 4 (11), pp. 3036-3048.
Autor:
Ippolito JE; Washington University in St. Louis, St. Louis, Missouri, United States., Hartig JP; Medical University of South Carolina, Charleston, SC, United States., Bejar K; The University of Texas Health Science Center at San Antonio, San Antonio, United States., Nakhoul H; Washington University in St. Louis, St. Louis, Missouri, United States., Sehn JK; Saint Louis University, St. Louis, MO, United States., Weimholt C; Washington University in St. Louis, St.Louis, MO, United States., Grimsley G; Medical University of South Carolina, United States., Nunez E; Washington University in St. Louis, St. Louis, Missouri, United States., Trikalinos NA; Washington University in St. Louis, St Louis, Missouri, United States., Chatterjee D; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kim EH; University of Nevada Reno, United States., Mehta AS; Medical University of South Carolina, Charleston, SC, United States., Angel PM; Medical University of South Carolina, Charleston, SC, United States., Troyer DA; Eastern Virginia Medical School, Norfolk, VA, United States., Leach RJ; The University of Texas Health Science Center at San Antonio, san antonio, tx, United States., Corey E; University of Washington, SEATTLE, WA, United States., Wu JD; Northwestern University, Chicago, IL, United States., Drake RR; Medical University of South Carolina, Charleston, South Carolina, United States.
Publikováno v:
Molecular cancer research : MCR [Mol Cancer Res] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.
Autor:
Zambrzycki SC; Department of Cell and Molecular Pharmacology, MUSC, Charleston, SC, USA., Saberi S; Hollings Cancer Center, Charleston, SC, USA., Biggs R; Department of Medicine, MUSC, Charleston, SC, USA.; The Ralph H. Johnson Department of Veteran's Affairs Medical Center, Charleston, SC, USA., Eskandari N; Department of Cell and Molecular Pharmacology, MUSC, Charleston, SC, USA., Delisi D; Department of Cell and Molecular Pharmacology, MUSC, Charleston, SC, USA., Taylor H; Department of Cell and Molecular Pharmacology, MUSC, Charleston, SC, USA., Mehta AS; Department of Cell and Molecular Pharmacology, MUSC, Charleston, SC, USA.; Hollings Cancer Center, Charleston, SC, USA., Drake RR; Department of Cell and Molecular Pharmacology, MUSC, Charleston, SC, USA.; Hollings Cancer Center, Charleston, SC, USA., Gentile S; Department of Cell and Molecular Pharmacology, MUSC, Charleston, SC, USA.; Hollings Cancer Center, Charleston, SC, USA., Bradshaw AD; Department of Medicine, MUSC, Charleston, SC, USA.; The Ralph H. Johnson Department of Veteran's Affairs Medical Center, Charleston, SC, USA., Ostrowski M; Hollings Cancer Center, Charleston, SC, USA.; Department of Biochemistry and Molecular Biology, MUSC, Charleston, SC, USA., Angel PM; Department of Cell and Molecular Pharmacology, MUSC, Charleston, SC, USA.; Hollings Cancer Center, Charleston, SC, USA.
Publikováno v:
Matrix biology plus [Matrix Biol Plus] 2024 Sep 25; Vol. 24, pp. 100161. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).
Autor:
Macdonald JK; Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina 29425, United States., Taylor HB; Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina 29425, United States., Wang M; Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina 29425, United States., Delacourt A; Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina 29425, United States., Edge C; Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina 29425, United States., Lewin DN; Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina 29425, United States., Kubota N; Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States., Fujiwara N; Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States., Rasha F; Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States., Marquez CA; Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States., Ono A; Department of Gastroenterology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan., Oka S; Department of Gastroenterology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan., Chayama K; Hiroshima Institute of Life Sciences, Hiroshima 734-8553, Japan.; Collaborative Research Laboratory of Medical Innovation, Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima 734-8553, Japan.; RIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan., Lewis S; Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States., Taouli B; Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States., Schwartz M; Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States.; Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States., Fiel MI; Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States.; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States., Drake RR; Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina 29425, United States., Hoshida Y; Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States., Mehta AS; Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina 29425, United States., Angel PM; Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina 29425, United States.
Publikováno v:
Journal of proteome research [J Proteome Res] 2024 Sep 06; Vol. 23 (9), pp. 3791-3805. Date of Electronic Publication: 2024 Jul 09.
Autor:
Rujchanarong D; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Bruker-MUSC Center of Excellence, Clinical Glycomics, Medical University of South Carolina, 173 Ashley Ave, Charleston, SC 29425, United States., Spruill L; Department of Pathology and Laboratory Medicine, Medical University of South Carolina, 96 Jonathan Lucas St. Ste. 601, MSC 617, Charleston, SC 29425, United States., Sandusky GE; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, 340 West 10th Street Fairbanks Hall, Suite 6200 Indianapolis, IN 46202-3082, United States., Park Y; Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Warf Office Bldg, 610 Walnut St Room 201, Madison, WI 53726, United States., Mehta AS; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Bruker-MUSC Center of Excellence, Clinical Glycomics, Medical University of South Carolina, 173 Ashley Ave, Charleston, SC 29425, United States., Drake RR; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Bruker-MUSC Center of Excellence, Clinical Glycomics, Medical University of South Carolina, 173 Ashley Ave, Charleston, SC 29425, United States., Ford ME; Department of Public Health Sciences, Medical University of South Carolina, 35 Cannon Street, Charleston, SC 29425, United States., Nakshatri H; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, 635 Barnhill Dr, Indianapolis, IN 46202, United States.; Department of Surgery, Indiana University School of Medicine, 545 Barnhill Dr, Indianapolis, IN 46202, United States., Angel PM; Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Bruker-MUSC Center of Excellence, Clinical Glycomics, Medical University of South Carolina, 173 Ashley Ave, Charleston, SC 29425, United States.
Publikováno v:
Glycobiology [Glycobiology] 2024 Jun 22; Vol. 34 (8).
Autor:
Hulahan TS; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC 29425, USA., Spruill L; Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA., Wallace EN; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC 29425, USA., Park Y; Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI 53726, USA., West RB; Department of Pathology Clinical, Stanford University, Stanford, CA 94305, USA., Marks JR; Department of Surgery, Duke University, Durham, NC 27710, USA., Hwang ES; Department of Surgery, Duke University, Durham, NC 27710, USA., Drake RR; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC 29425, USA., Angel PM; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC 29425, USA.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Jun 19; Vol. 25 (12). Date of Electronic Publication: 2024 Jun 19.
Autor:
Hodgson K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Orozco-Moreno M; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Goode EA; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Fisher M; The Mellanby Centre for Musculoskeletal Research, Division of Clinical Medicine, The University of Sheffield, Sheffield, UK., Garnham R; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Beatson R; Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London (UCL), Rayne 9 Building, London WC1E 6JF, UK., Turner H; Cellular Pathology, The Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK., Livermore K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Zhou Y; The Mellanby Centre for Musculoskeletal Research, Division of Clinical Medicine, The University of Sheffield, Sheffield, UK., Wilson L; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Paul O'Gorman Building, Newcastle upon Tyne NE2 4HH, UK., Visser EA; Synthetic Organic Chemistry, Institute for Molecules and Materials, Radboud University, Nijmegen, the Netherlands., Pijnenborg JF; GlycoTherapeutics B.V., Nijmegen, the Netherlands., Eerden N; Synthetic Organic Chemistry, Institute for Molecules and Materials, Radboud University, Nijmegen, the Netherlands; GlycoTherapeutics B.V., Nijmegen, the Netherlands., Moons SJ; Synvenio B.V., Nijmegen, the Netherlands., Rossing E; Synthetic Organic Chemistry, Institute for Molecules and Materials, Radboud University, Nijmegen, the Netherlands., Hysenaj G; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Krishna R; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Peng Z; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Nangkana KP; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Schmidt EN; Department of Chemistry, University of Alberta, Edmonton, AB T6G 2G2, Canada; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB T6G 2E1, Canada., Duxfield A; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK; International Centre for Life, Biosciences Institute, Newcastle University, Newcastle Upon Tyne NE1 3BZ, UK., Dennis EP; International Centre for Life, Biosciences Institute, Newcastle University, Newcastle Upon Tyne NE1 3BZ, UK., Heer R; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Paul O'Gorman Building, Newcastle upon Tyne NE2 4HH, UK; Department of Urology, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE7 7DN, UK., Lawson MA; The Mellanby Centre for Musculoskeletal Research, Division of Clinical Medicine, The University of Sheffield, Sheffield, UK., Macauley M; Department of Chemistry, University of Alberta, Edmonton, AB T6G 2G2, Canada; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB T6G 2E1, Canada., Elliott DJ; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Büll C; Biomolecular Chemistry, Institute for Molecules and Materials, Radboud University Nijmegen, the Netherlands., Scott E; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK., Boltje TJ; Synthetic Organic Chemistry, Institute for Molecules and Materials, Radboud University, Nijmegen, the Netherlands., Drake RR; Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, SC, USA., Wang N; The Mellanby Centre for Musculoskeletal Research, Division of Clinical Medicine, The University of Sheffield, Sheffield, UK; Leicester Cancer Research Centre, Department of Genetics and Genome Biology, University of Leicester, LE2 7LX, UK. Electronic address: nw208@Leicester.ac.uk., Munkley J; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle upon Tyne NE1 3BZ, UK. Electronic address: Jennifer.munkley@ncl.ac.uk.
Publikováno v:
EBioMedicine [EBioMedicine] 2024 Jun; Vol. 104, pp. 105163. Date of Electronic Publication: 2024 May 20.
Autor:
Scott E; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Archer Goode E; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Garnham R; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Hodgson K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Orozco-Moreno M; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Turner H; Cellular Pathology, The Royal Victoria Infirmary, Newcastle upon Tyne, UK., Livermore K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Putri Nangkana K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Frame FM; Cancer Research Unit, Department of Biology, University of York, North Yorkshire, UK., Bermudez A; Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University, Palo Alto, CA, USA., Jose Garcia Marques F; Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University, Palo Alto, CA, USA., McClurg UL; Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, UK., Wilson L; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, UK., Thomas H; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, UK., Buskin A; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, UK., Hepburn A; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, UK., Duxfield A; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Bastian K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Pye H; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Arredondo HM; The Mellanby Centre for Musculoskeletal Research, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, UK., Hysenaj G; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Heavey S; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Stopka-Farooqui U; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Haider A; Department of Pathology, UCLH NHS Foundation Trust, London, UK., Freeman A; Department of Pathology, UCLH NHS Foundation Trust, London, UK., Singh S; UCL Centre for Medical Imaging, Charles Bell House, University College London, London, UK., Johnston EW; UCL Centre for Medical Imaging, Charles Bell House, University College London, London, UK., Punwani S; UCL Centre for Medical Imaging, Charles Bell House, University College London, London, UK., Knight B; NIHR Exeter Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., McCullagh P; Department of Pathology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., McGrath J; Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Crundwell M; Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Harries L; Institute of Biomedical and Clinical Sciences, Medical School, College of Medicine and Health, University of Exeter, Exeter, UK., Heer R; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, UK.; Department of Urology, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Maitland NJ; Cancer Research Unit, Department of Biology, University of York, North Yorkshire, UK., Whitaker H; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Pitteri S; Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University, Palo Alto, CA, USA., Troyer DA; Cancer Biology and Infectious Disease Research Center, Eastern Virginia Medical School, Norfolk, VA, USA., Wang N; The Mellanby Centre for Musculoskeletal Research, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, UK., Elliott DJ; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Drake RR; Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, SC, USA., Munkley J; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK.
Publikováno v:
The Journal of pathology [J Pathol] 2023 Sep; Vol. 261 (1), pp. 71-84. Date of Electronic Publication: 2023 Aug 07.